213 related articles for article (PubMed ID: 2404028)
1. Stage-related proliferative activity determines c-myb functional requirements during normal human hematopoiesis.
Caracciolo D; Venturelli D; Valtieri M; Peschle C; Gewirtz AM; Calabretta B
J Clin Invest; 1990 Jan; 85(1):55-61. PubMed ID: 2404028
[TBL] [Abstract][Full Text] [Related]
2. Regulation of proliferation and cytokine expression of bone marrow fibroblasts: role of c-myb.
Szczylik C; Skorski T; Ku DH; Nicolaides NC; Wen SC; Rudnicka L; Bonati A; Malaguarnera L; Calabretta B
J Exp Med; 1993 Sep; 178(3):997-1005. PubMed ID: 7688794
[TBL] [Abstract][Full Text] [Related]
3. Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase alpha.
Valtieri M; Venturelli D; Caré A; Fossati C; Pelosi E; Labbaye C; Mattia G; Gewirtz AM; Calabretta B; Peschle C
Blood; 1991 Mar; 77(6):1181-90. PubMed ID: 1705831
[TBL] [Abstract][Full Text] [Related]
4. A functional analysis of protooncogene Vav's role in adult human hematopoiesis.
Luger SM; Ratajczak J; Ratajczak MZ; Kuczynski WI; DiPaola RS; Ngo W; Clevenger CV; Gewirtz AM
Blood; 1996 Feb; 87(4):1326-34. PubMed ID: 8608221
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
Szczylik C; Skórski T; Malaguarnera L; Hetman J; Chen ST; Calabretta B
Folia Histochem Cytobiol; 1996; 34(3-4):129-34. PubMed ID: 8967957
[TBL] [Abstract][Full Text] [Related]
6. Growth factor-dependent inhibition of normal hematopoiesis by N-ras antisense oligodeoxynucleotides.
Skorski T; Szczylik C; Ratajczak MZ; Malaguarnera L; Gewirtz AM; Calabretta B
J Exp Med; 1992 Mar; 175(3):743-50. PubMed ID: 1371302
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
[TBL] [Abstract][Full Text] [Related]
8. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms underlying erythropoiesis: cycling activity of adult BFU-e relates to their requirement for c-myb function and potential for HbF synthesis.
Valtieri M; Gabbianelli M; Pelosi E; Testa U; Labbaye C; Mattia G; Fossati C; Venturelli D; Gewirtz AM; Calabretta B
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():314-34. PubMed ID: 1691249
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
11. Expression and physiologic significance of Kit ligand and stem cell tyrosine kinase-1 receptor ligand in normal human CD34+, c-Kit+ marrow cells.
Ratajczak MZ; Kuczynski WI; Sokol DL; Moore JS; Pletcher CH; Gewirtz AM
Blood; 1995 Sep; 86(6):2161-7. PubMed ID: 7545021
[TBL] [Abstract][Full Text] [Related]
12. Role of the KIT protooncogene in normal and malignant human hematopoiesis.
Ratajczak MZ; Luger SM; DeRiel K; Abrahm J; Calabretta B; Gewirtz AM
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1710-4. PubMed ID: 1371882
[TBL] [Abstract][Full Text] [Related]
13. Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides.
Ratajczak MZ; Hijiya N; Catani L; DeRiel K; Luger SM; McGlave P; Gewirtz AM
Blood; 1992 Apr; 79(8):1956-61. PubMed ID: 1562723
[TBL] [Abstract][Full Text] [Related]
14. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
15. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
16. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
17. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
19. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
[TBL] [Abstract][Full Text] [Related]
20. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
